Vildagliptin & Metformin (50+850 mg), (50+1000 mg) Film Coated Tablets (under development)

Product description

Vildagliptin & Metformin(50+850 mg), (50+1000 mg) Film Coated Tablets Reference Product: Eucreas® / Novartis
Description: Vildagliptin & Metformin is a combination of 2 anti-diabetic agents indicated in the treatment of type 2 diabetes mellitus. More specifically, it is indicated:- In the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- In combination with a sulphonylurea or insulin as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea or insulin.Dossier Status: On-going Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Two (2) years (PA/Alu/PVC/Alu ) or 18 months (PCTFE/PVC/Alu)
Batch Sizes: 100.000 tablets (commercial up to 1.000.000 tablets)
Pack Sizes: To be defined / Originator pack: Box x 10, 30, 60, 120, 180 & 360 tablets

Specifications

Categories	Finished Dosage FormsOut-licensing; Finished Dosage FormsTablets
Sales markets	Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from	Greece

More products from ANFARM HELLAS S.A.

Linezolid 2mg/ml (300ml Plastic Bag) (EU CTD Available)

Linezolid 2mg/ml (300ml Plastic Bag) Solution for Infusion
Reference Product: Zyvoxid® / PFIZER
Description:Linezolid is a synthetic antibacterial agent that belongs to oxazolidinones. It has in vitro activity against aerobic Grampositive bacteria and anaerobic micro-organisms. Linezolid selectively inh...

More info

Dalbavancin 500mg Powder for concentrate for solution for infusion (under development)

Dalbavancin 500mg Powder for concentrate for solution for infusion
Reference Product: Xydalba® / Allergan Pharmaceuticals International Ltd
Description: Dalbavancin is a glycopeptide antibacterial which is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adul...

More info

Daptomycin 350 & 500mg/Vial (EU CTD Q1: 2021)

Daptomycin 350 & 500mg/Vial Powder for Solution for Injection or Infusion
Reference Product: Cubicin® / MSD Description:Daptomycin is an antibacterial (cyclic lipopeptide natural product) that is active against Gram positive bacteria and is indicated for the treatment of the following infecti...

More info

Brivaracetam 10mg/ml (5ml Vial) (EU CTD: 2022)

Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
Reference Product: Briviact® / UCB
Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and ch...

More info

Isavuconazole 200mg Powder for concentrate for solution for infusion (under development)

Isavuconazole 200mg Powder for concentrate for solution for infusion
Reference Product: Cresemba® / Basilea Pharmaceutica (Pfizer)
Description: Isavuconazole is an antifungal agent which is indicated in adults for the treatment of:
• invasive aspergillosis
• mucormycosis in patients for whom ampho...

More info

Tigecycline 50 mg/Vial Powder for Solution for Infusion (EU CTD Q4: 2020)

Tigecycline 50 mg/Vial Powder for Solution for Infusion Reference Product: Tygacil® / Pfizer
Description: Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunitand blocking entry of amino-acyl tRNA molecules into the A site of the ribo...

More info

View all our products (30)